1-94530263-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001993.5(F3):c.*197G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.296 in 580,954 control chromosomes in the GnomAD database, including 27,202 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.29 ( 6481 hom., cov: 31)
Exomes 𝑓: 0.30 ( 20721 hom. )
Consequence
F3
NM_001993.5 3_prime_UTR
NM_001993.5 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.0310
Publications
15 publications found
Genes affected
F3 (HGNC:3541): (coagulation factor III, tissue factor) This gene encodes coagulation factor III which is a cell surface glycoprotein. This factor enables cells to initiate the blood coagulation cascades, and it functions as the high-affinity receptor for the coagulation factor VII. The resulting complex provides a catalytic event that is responsible for initiation of the coagulation protease cascades by specific limited proteolysis. Unlike the other cofactors of these protease cascades, which circulate as nonfunctional precursors, this factor is a potent initiator that is fully functional when expressed on cell surfaces, for example, on monocytes. There are 3 distinct domains of this factor: extracellular, transmembrane, and cytoplasmic. Platelets and monocytes have been shown to express this coagulation factor under procoagulatory and proinflammatory stimuli, and a major role in HIV-associated coagulopathy has been described. Platelet-dependent monocyte expression of coagulation factor III has been described to be associated with Coronavirus Disease 2019 (COVID-19) severity and mortality. This protein is the only one in the coagulation pathway for which a congenital deficiency has not been described. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Aug 2020]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.457 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.287 AC: 43537AN: 151750Hom.: 6488 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
43537
AN:
151750
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.299 AC: 128312AN: 429086Hom.: 20721 Cov.: 6 AF XY: 0.302 AC XY: 67051AN XY: 221892 show subpopulations
GnomAD4 exome
AF:
AC:
128312
AN:
429086
Hom.:
Cov.:
6
AF XY:
AC XY:
67051
AN XY:
221892
show subpopulations
African (AFR)
AF:
AC:
3189
AN:
12460
American (AMR)
AF:
AC:
3863
AN:
16614
Ashkenazi Jewish (ASJ)
AF:
AC:
3816
AN:
12332
East Asian (EAS)
AF:
AC:
13269
AN:
29246
South Asian (SAS)
AF:
AC:
13708
AN:
31566
European-Finnish (FIN)
AF:
AC:
10456
AN:
26450
Middle Eastern (MID)
AF:
AC:
637
AN:
2738
European-Non Finnish (NFE)
AF:
AC:
72154
AN:
273170
Other (OTH)
AF:
AC:
7220
AN:
24510
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
3996
7991
11987
15982
19978
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
890
1780
2670
3560
4450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.287 AC: 43534AN: 151868Hom.: 6481 Cov.: 31 AF XY: 0.296 AC XY: 21948AN XY: 74196 show subpopulations
GnomAD4 genome
AF:
AC:
43534
AN:
151868
Hom.:
Cov.:
31
AF XY:
AC XY:
21948
AN XY:
74196
show subpopulations
African (AFR)
AF:
AC:
10665
AN:
41424
American (AMR)
AF:
AC:
3805
AN:
15242
Ashkenazi Jewish (ASJ)
AF:
AC:
1112
AN:
3466
East Asian (EAS)
AF:
AC:
2440
AN:
5158
South Asian (SAS)
AF:
AC:
2272
AN:
4810
European-Finnish (FIN)
AF:
AC:
4194
AN:
10520
Middle Eastern (MID)
AF:
AC:
78
AN:
294
European-Non Finnish (NFE)
AF:
AC:
18226
AN:
67936
Other (OTH)
AF:
AC:
531
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1581
3161
4742
6322
7903
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
458
916
1374
1832
2290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1586
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.